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XANTHOMATO IS ASSOCIATED WITH 
HYPERLIPOPROTEINEMIA 
FRA TK PARKER, M.D. ru."l o JOHN M. SHORT, M.D. 
Xanthomas, in them elves, are usually harm-
less. However, t hey frequently occur in patients 
with atherosclerosis and abnormal lipoprotein 
meLabolism. Therefore, studies dealing with 
xanlhomas in experimental animals nnd hu-
mans, in wlwm hyper!ipoproteinemia is present, 
may lead to useful information about the 
mann er in 11·!Jich lipids accumulate in t he foam 
cells of xant homas and, more important, how 
the pathologic processes in the skin migh t 
mirror eYcnts occurring in the foam cells of 
at.beroscleroLic p laques. 
This ar ticle will review some of the current 
concept of the biochemical and morphologic 
abnormalities occurring in xanthomas as de-
rived from studies of these cutaneous lesions in 
humans and experimental animals . This will 
include a. discu sion of the metabolism of cer-
tain lipopro teins o£ importance in xnnthomato-
sis as well as a consideration o£ the new 
hyperlipoprotein syndromes described by Fred-
rickson et al. (1) as they relate to various 
forms of xanthomas. Where possible, an at-
tempt is made to correlate the pathologic and 
biochemical alterations observed in xanthomas 
wi t h tho ·e occurring in atheromas. 
Li7Joproteins of Importance in 
X anlhomatosis 
Lipoproteins are the physiologic form in 
which otherwise water insoluble lipids are 
transported in the plasma. An understanding of 
t he formation, metabolism and physical charac-
teristics of t hree groups of lipoproteins is use-
ful in th is di cus io u of x::mt!Joma.s fo r several 
reasons. First, it is possible to more precisely 
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delineate the diseases associated with xantho-
matosis ( 1) by ident ifying specific lipoprotein 
n!terations. Second, a more rational app roach 
to t reating t hese hyperlipoproteinemic condi-
tions is possible when lipoprotein synthetic 
and catabolic processes are understood. Last, 
the pnthologic events occurring within various 
types of xanthomas become clearer when con-
idered in the context o£ specific plasma lipo-
proteins. 
For the purpose of this review, the salient 
metaboli c and physical chnracteristics of three 
group of lipoproteins will be discussed: the 
beta ({3) and pre-beta (pre-{3) lipoproteins and 
t he chylomicrons. 
Each group of lipoproteins has unique chemi-
cal, metabolic and phy iologic characteristics 
which are diagrammatically pictured in Figure 
1 and more precisely recorded in Table I (1-4). 
Although lipoproteins contain small amounts of 
protein (apoprotein) and phospholipid, the 
t wo major lipid components, cholesterol and 
triglyceride, are of primary concern to this dis-
cussion. 
f3 and pre-{3 lipoproteins, both formed in the 
liver, diller in size and vary in regard to the 
relative amounts of cholesterol and t riglyceride 
which t hey carry (Fig. 1) . The small sized {3-
lipoproteins carry large quantities of cholesterol 
and very little t riglyceride. Triglycerides, on 
the other hand, represent half of the lipid found 
in pre-(3 lipoproteins with cholesterol con-
tributing only 30% o£ the lipid by weight 
(Table I) . Pre-{3 lipoproteins are of sufficient 
size to scatter t ransmitted light , so that if 
found in large concent rations in the plasma 
they will cause the plasma to appear milky or 
li pemic. The pre-{3 lipoproteins are sometimes 
referred to as "carbohydrate induced" or en-
dogenous lipoproteins because dietary carbo-
hydrate is converted t o t riglyceride which in 
t urn is incorporated into the pre-{3 lipoproteins 
(5, 6). Thus, a high carbohydrate diet ulti-
mately results in an increase in the plasma con-
centration of these pre-{3 lipoproteins. 
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METABOLISM OF LIPOPROTEINS 
OF IMPORTANCE IN XANTHOMATOSIS 
Ll 
I<ra. 1. The lipid compo it.ion and relative size 
of three n-rou ps of Upopro teins; {3, pre-{3 and chylo-
microns (chylos), are depicted. Bl ack portion = 
total cholesterol, dotted shading = triglyceride, 
and open portion = apoprotein and phospholipid . 
(3 and pre-(3 li poproteins are synthesized in the 
liver while chylomicrons are formed in the intesti-
nal wall and trans1 orted vin. the lymph::t tics to the 
circulation where th ey are cleared by a lipolyti c 
enz~·me, li poprotein lipase (LPL) , for storngc in 
adipose tissue cells. Cholesterol (cbolest.), cn rried 
primaril y bv f3 and pre-{3 lipoproteins, is de1·ivecl [rom bo th .dietary intake and local synthesis with in 
the li ver, here abbreviated as onJy 2 steps: HMG-
CoA (hyclro::o.'Ymethy lg]utarvl CoA)-> MVA (mev-
alonic acid) . Cholesterol is hydroxylated to b il e 
acids which .~ re discharged in lo the intestinal lu-
men to aid in fat absorption and are then re-
absorbed themselves to be rctumed to tbe cho-
leslerol-bile acid l1 epati c pool. Triglycerides, 
transported mauuy in pre-(3 and chylomicron lipo-
proteins, are derived from dietary carbohydrates (ca rbo.) nod fats (TG) respectively. Free fatty 
acids (FFA) ut,iJized in triglyceride synthesis in 
th liver are obtained from hydrolysis of stored 
triglycerides of the adiJ ose cells. 
In contrast, the third lipoprotein group, the 
chylomicrons, are formed in the intestinal wall 
from exogenous fats (triglycerides) ingested in 
the diet. Therefore, they are sometimes referred 
to as "exogenous" or "fat-induced" lipoproteins 
since their plnsm.a concentra.tion rises in re-
sponse to diets high in fats (6). Chylomicrons 
are composed mainly of triglycerides (85%) 
reflecting the incorporation of dietary triglyc-
ericles into these particles during their synthesis 
in the intestinal wall. Plasma chylomicron 
concentration depends both on synthesis and 
degradation of chylomicrons. Clearance of 
chylomicron · from the circulation, for either 
tissue uti li zation or slorage in adipose t issue, is 
regulated by the hydrolysis of t riglycerides 
carried in the ·e particles . This ltydrolysis is 
catalyzed by an enzyme, lipoprotein Jipn e 
(LPL, Fig. 1) (sometimes also referred to as 
post-heparin lipolytic activity or PHLA). The 
activity of this enzyme dep nels on normal 
utilization of insulin since patients wit h 
diabetes mellitus and insulin insufll.ciency haYe 
low activity levels of this enzym e and are un-
able to clear chylomicrons from their pla ma 
(7). As can be seen from Figure 1 and T able I , 
chylomicrons are of hrge size and thus rea dily 
cause lipemia similar to endogenous, or pre-(3, 
lipoproteins . 
In order to enhance understanding of ther-
apy of lipoprotein disorders, a 'few additional 
points should be made regarding the synthe is 
and catabolism of the cholest erol and triglyc-
erides which contribute to lipoprotein forma-
tion. Cholesterol is obtained from two source , 
that ingested in the diet and that synthe izecl 
in the liver (Fig. 1) . The rate of cholesterol 
synthesis in the liver is regulated by t he 
amount taken in the diet, the rate of synthe is 
being inversely propor tional to the amount in-
gested. Cholesterol synthesis is depicted in an 
abbreviated fashion in Figure 1 in t he followin g 
sequence: hydro:>rymethylglutaryl CoA (HMG-
CoA) ~ mevalonic acid (MVA) -7 cholesterol 
(CHOL.) . Some of the cholesterol is catabo-
lized by hydroxylation to bile acids, which are 
secreted into the intestine via the bile duct to 
aid in fat (triglyceride) absorption. After the 
triglycerides are absorbed, nlmost all of the 
bile acids are also reabsorbed, completing the 
enterohepatic cycle of cholesterol-bile acid 
metabolism. Under normal physiologic condi-
tions, t he small amount of new bile acid syn-
thesized each day from cholesterol just equals 
that amount lost in the feces. 
Triglyceride is also derived from two 
sources-the diet and synthesis within the 
liver. Synthesis of triglyceride depends upon 
the availability of the two components of this 
lipid-glycerol and free fatty acid . Glycerol is 
obtained from a number of sources in the 
liver, but of particular importance is the 
metabolism of dietary carbohydrates. Ingestion 
of large amounts of carbohydrate stimulates 
the liver to increase both trirrlycericle synthesis 
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TABLE I 
Important clwracteris tic~ of lipo7J I'Oteins associated with :ranthollla/os'is* 
Method of Lipid content 
SCI)arution % total li pid 
Approximate Origi n Produce Oll1cr size li pemia 
Paper Sft Total TG chol. 
{:J {:J 0- 20 50% 10cio 200- 250 A Li ve r 0 
P re-13 Pre-13 20--100 3:2 ( 50'; ~ 3oo-woo A. Liver (en- 1-3+ C:trbohy-
doge- dr .-in-
JlOllS) clueed 
Ch~· l omi c runs O r.igin > ~ 00 10~'~ s5('c woo-5ooo A Intest in e -1+ Fat-in -
(cxogc- duced 
I nons) 
* These th ree grottps of li popro teins can be. t be thought of ns a :o;pectntm. On one ext rome arc the 
dirniuuLivc cholesterol-ri ch 13-li poproteiJJs which float raLher s lowl y in t he ultracent rifuge. On Lhc 
other end of the continuum are the ve ry l:Lrgc t riglyccride-la len chylomi crons whi ch fJ.oat rapid ly 
when s ubj ccLed to ultraccntrifug:t. Lion , buL do noL move from Lhe origin on Lh e p:tper elecLropboret ic 
separat ions. Prc-13 lipoprote ins fall somewh re between being of inte rrn cdiaLe s ize nncl carrying s igni fi-
can t q uant.it ies of bo lh cholc Lcrol and Lri glyceri.cl c. In t he ullraccn trifugc t heir fl otat ion ra te rnngcs 
beLwecn Lhn L o[ {3 lipoproteins and hylomi crnns. 
t U.ltraccn t. ri fugnt ion fl otation uni t.. 
and t he subsequent formation of pre-(3 lipo-
p roteins . The free fatty acids are derived from 
t he hydrolysis of triglycerides stored in adipose 
t issue (Fig. 1). 
It should be obvious that elevated plasma 
cholesterol and triglyceride concentrations in 
disease states will depend on increased amounts 
of t he specific lipopro tein (s). Therefore, (3-
lipoproteins cause an i11crease p rimnril y in 
cholesterol, whil e chylomicronemia results in an 
elevation predominantly of triglycerides. The 
p re-(3 lipoproteins produce increases in both 
cholesterol and t riglyceride in t he plasma. 
The last point to consider in discussing lipo-
p roteins is the methods used in their separation 
and identification (Table I). P aper electro-
phoresis (8) has been particularly useful in 
iclent ifyi11g various hyperlipoproteinemic syn-
dromes (1) because it readily separates (3 and 
pre-(3 lipoproteins and chylomicrons. However, 
this is only a sem iquantitative method and 
therefore ult rancentrifugation is a useful ancil-
lary means of quantifying lipoproteil1 abnor-
malities (9) . The rate of flotation of lipopro-
teins i!l a high cent rifugal field is expressed as 
Svedberg flota tion, or Sf, units . TlJU (3-lipo-
proteins, so named because they move with the 
(3-globulins of the plasma on paper electro-
phoresis, correspond to lipoproteins with an 
Sf 0-20. Pre-(3 lipoproteins, which derive t heir 
name from t he fact t hat they move fu r ther 
from the origin than (3 on paper electrophore-
sis, float in the ult racentrifuge at a faster rate 
of Sf 20-400. Triglyceride rich chylomicrons, 
which remain at t he point of origin on paper 
electrophoresis, float even more rapidly in the 
ultracentrifuge at a rate of Sf > 400. It can be 
seen t hat t he greater the amount of triglyceride 
carried by a lipoprotein particle, t he larger will 
be its size and the faster it will float in the 
uJ t racentrif uge. 
H Y1Jerlipoproteinemic Syndromes in 
Xanthomatosis 
Disorders of lipoprotein m etabolism are 
classified into two major groups. Primary hy-
perlipoproteinemia is usually a familial dis-
order in which abnormal lipoprotein metabo-
lism is t he result of an inborn error in 
metabolism which is generally relatively resist-
ant to t herapy {1, 10, 11). 
T able II classifies t he various primary and 
secondary diseases associated wit h hyperlipo-
proteinemia. The major groups of diseases are 
fur ther subd ivided according t o specific lipo-
protein abnormalities along wit h associated 
abnormalities of p lasma cholesterol and/or 
t riglycerides . 
Additional attention is given to t he five 
primary hyperlipoproteinemic syndromes in 
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TABLE II 
C'la ssi.fi cai'ion of xonlho11W io1lS ili.~ea., e., 
P ri nwr.r .ll y perlipoproleinl'rnin (J) 
ln crenRcd {3-lipoprnt ein :> (e lcvatrrl choles terol wiLhont liprmin ) 
T~· pe JT- Jca milia l h.y pc't·cholcs trrulcmi :t (14, 15) 
Jn(:J·cnsrd chylomic-rons (clcv nLctl t ri glyccrides w ith marked lipemi a) 
T ype T- F:nnili al faL-induced lipemi a (G, 12) 
In rr:l:Wd f3 and Jre-{3 lipopt·o eins (elcvaLed cholesterol :wd lriglyccrides w it. lt mi.ld lipemi a) 
Type llJ- Broad bet'' disense (1, JO) 
In ereasccl prc-{3 I ipoproleins (elevnted cholus l •rot and 1 ri ~ l yce rid c with mnd crat c I ipcmia) 
T ype lV- li'ami li al carbohydr:l.ll' -indu ced lipemi n (1, JG, 17) 
] nc rcnsed pre-{3 li poproteins a nd chylomi cJ·ons (elcv:llcd chulcsle rul and t ri "'lyccride wit h 
m:lrked lipemi a) 
Ty pe V-F~mi li :d ful - and carbohy lrnle- indll('cd li pcmi r, (1, lG) 
Sccundary J Jy perlipoprot ci ncm i a 
Jn cr·ased {3-lipnpro tcins (clcv nt ecl cholcs Le rol wilhouL li pemia ) 
Ob.- tt·t tclive Ji vP r diRease (l!l- :21) 
Jn ercasod cltylomi orons and pro-{1 lipop r1>1 eins (elcv :tll'd l ri~ l yce rid c . :md clt olcs lerol wil h 
li pC'mia) 
DiaboLos mel! i Lu:s (7 , 22 , 2:3) 
]'an c r :LI.i li s (24, 25) 
No n -JJ ephrntic memi a (2!i) 
Al co hol-indtt ·ed li pemia (27-30) 
Li poalrophic din.betes (31) 
Lupus eryt hematosus nnd Jymph om:\ (32) 
I nc r •ased pre-{3 lipoprot eins (elev aLod cholcsle rol and tri glyce rid e wiLh no to modemt c 
li pemi a) 
Ulycogen sloragc di sease (33) 
EsLrog •n hormones and pregnan cy (3'1) 
Dysglob ulincmin (m 111Liple myelormt) (35, .'30) 
In creased fl, pl'e-{3 1ipoprol• ins nnd chyl mi cron.- (elevat ed cho'l es tcrol :md t. ri gly<· cride w ith 
no to mndcrn lc Ji pemi n) 
Myxedema (27 , :38 ) 
_ cphrol ic sy ndrome (39) 
T all e III. The criteria for diagnosing t hese 
syndromes have been provided by t he elegant 
s tudies of Fredrickson et al. (1) and t he 
nomencln.ture proposed by these investigators, 
T ypes I-V, is used. 
cron clearing enzyme, lipoprotein lipase (l , 
13) (see Fig. 1). When t he patien t's fasting 
serum is allowed to stand overnight at 4 oc, a 
heavy cream l:lyer of ehylomicrons forms on 
the surface with clear serum below (Table 
III) . Clinical find ings include abdominal pain , 
hepatosplenomegaly, severe lipemia and erup-
t ive xanthomas. 
T ype I , originally described by Burger and 
Griitz (12) as familial hyperlipemia, is charac-
terized by increased cbylomicrons and elevated 
p lasma t ri p;l ~· cc ridc in tlte fasting stale . The 
·ypicn I paper electrophoret ic pattern, with a 
heavy lipid concent rat ion at t he origin , is 
shown on T able III . The syndrome is some-
times referred to as "fat-induced" or "exoge-
nous" hyperlipemia because a marked rise in 
circulating chylomicrons is observed after in-
gestion of a diet hi"h in fat (5, 6). This ac-
cumulation of cbylomicrons is t he r esult of a 
recessively inherited deficiency of the chylomi-
T ype II, familial hypercholesterolemia, is a 
dom inantly inherited abnormality in t he basic 
homeoslatic mechanisms for maintaining nor-
mal circulating levels of f3-Epoproteins . As a 
resul t, t here is in a heavy ,8-lipoprotein band 
on paper electrophoresis, an elevated plasma 
cholesterol and clear serum (since f3 are of 
small size) both before and after serum is re-
fr igerated at 4oC for 24 hours (Table III). 
There is a high incidence of premature athero-
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sclerosis and myoc::udial in farction with asso-
ciated tend inous xanthoma , xanthelasma and 
arcus scnilis (1, 14, 15). 
T ype Ill is sometimes referred to a "b road 
bcl:l di,c:lsc" brca l kC 1 he chnn1cie ristic in-
crense in both f3 and p re-(3 lipopro teins pro-
duces a cont inuo11s or bro::tcl band of lipid on 
t he paper electrophoretic strip (T:1blc I II ) 
(1, 16). Both pia ·ma cholesterol and t rig! c-
erides are elev:1ted since t hese two groups of 
lipoprot ins together carry significant, quanti-
t ie.: o l' these lip id,;. Th e cli!'t ur l.w nce in ihis ~ ~·n­
drome seems to be an anomaly in lipoprotein 
formation since no t on ly are t he (3-lipopro teins 
in crea~ed in amount but they are also abnor-
mally belen with tr i"'lycerides and thus h:1ve an 
unusual charge whicu causes them to "smear" 
bet1rccn t he f3 :mel pre-(3 bands on paper elec-
t rophoresis (1). The diagnosis requires t he 
use of ult racent ri fuga.I methods to show that 
some of t he lipoproteins migrating a f3 on 
pa per actually h:w e an Sf similar to pre-(3 
(Sf 20-400). In some instances, small amounts 
of chylomicrons are also observed in the fasting 
st~1.te an I these contain an abnormally high 
concentration of cholesterol. Fasting serum 
samples from such p::~ t i ents, allowed to stand 
o 1·el'lli ~ ilt , Y : lr~ · from cl :1r to turb id depe nding 
on t he amount of t he large-sized pre-(3 lipo-
p roteins in the circulation (Table III ). A com-
bination of t uberou and erupt ive xan thomas 
("tuberoeru ptive") are seen in associa tion with 
ca rdiovascular compli cations and mi.lcl glucose 
in toler:mce. Flat to t uberous xanthomas on t he 
palms and fin gertips are said to be characteris-
t ic (1). 
T ype IV hyperlipoprotcinerniC~ is also re-
ferred to as "c:nbohydrate-incluccd" or "en-
dogenous" lipemia because diets high in 
carbohydrates accentuate the lipoprotein ab-
norma.!ities i1J these patients (Tables I and III) 
(5, 6, 16, 17) . P aper electrophoresis displays a 
he.wy pre-(3 lip id band (16 ). P lasma choles-
terol and triglycericles are increased refl ecting 
the fact t hat t hese are the major lipids carried 
by thi lipoprotein group (Tables II and III). 
Serum from such patients, allowed to stand 
overnight at 4°C, results in marked turbidity 
t hroughout t he sample (Table III) . As in T ype 
I fat-indu ced lipemia, abdominal pain, hepato-
splenomegaly, and lipemia retinalis are seen, 
but in con trast, T ype IV patients have an in-
creased incidence of premature atherosclerosis 
TA.BLE III 
CHARACTER! STICS OF 
PRIMARY HYPERLI POPROTE I NEM I C CO NDITI ONS 
PLASMA* PAPER SERUM TYPE LP ELECTRO· FEATURES LIPIDS PHORESIS AT 4'C 
I ~ Cholest 150·400 ~i""' ~~ Eruptive xan th_ TG 800-4000 t Live r, spleen Chyle pre ·/3 Abdom pam 
n f) Cholesl 275·600 Bi"" U! 
Tendinous xonth. 
TG 75-200 Xanthe lasma 
/3 pre -{3 Arcus senilis 
Atherosclerosis 
ill ~ Cholesl 300·800 ~i"" I' TuberoerupTive TG 300-1500 L xonlh . 0 /3 pre·{3 pre ·{3 u Atherosclerosis ~ Glue. inlol . 
N. ~ '"'"" '"'roo ~ '"" ?Erupt ive xanlh. TG 200·500 . ... {3 I' Atherosclerosis pre ·f3 pre ·f3 0 Glue in lol. u ~ 
• 
Choles. 250-600 ~'"·'· Eruptive xonth. ;;z TG 600-4000 {3 l t Liver, spleen L pre ·{3 0 Abdom. poin pre·f3chylo ~ 
The labontl ory :lllcl cli n ieal eharnctcri tics of 
l he 11ve hypertipop rol;cinem ic eon cl i lions :1rc 
s11mm ari zcd. The features of each syndrome arc 
self-eviden t fro m this chart excep L pe rhaps for 
t he fi ndings in the palicnL's ~e ra nflc r iLt ing >Lt 
4°C fo r 24 hours. When ·era after nn overnight 
fast is examin rd in thi s wn.y, chylomicrons fl oat 
Lo the surfnce of t he sera l,o fo rrn :1 heavy cren m 
layer (shown i11 bl ack), whi le p rc-!3 li poproteins 
rcmu. in dispersed I broughon L the sampl e providin g 
>Lgcn er:<li zcd l11rbidi ty (:'< hown ns cmss-ha tching) . 
*No rm al values afte r an oven1igh L fast: T oln.l 
choles erol (cholest.) np Lo 275 mgo/' i11 p:1.t. icnls 
under 20 yea rs of age and up Lo 2!)0-300 mg% 
over 20. Triglycc riclcs (TC: ) up to 140 mg% under 
20 and up to 175 mg% ove r 20. 
nnd glucose intolerance (1, 16). T ype IV pa-
t ients a.rc m::~ cle worse by high-ca rbohyd rate 
l01r-fat di ets, just the reverse of p::ttients " ·ith 
t he Type I syndrome. Although eruptive 
xanthomas are said to occur in t his syndrome 
(1 , 18) t his has not been a prominent fenture 
in t he patients seen by the authors. 
T ype V, a combination of T ype I and IV 
syndromes, is characteri zed by increases in 
pre-(3 lipoproteins and chylomicrons. On paper 
electrophoresis, heavy bands of lipid are ob-
served in the pre-(3 and origin or chylomicron 
posit ions (Table III) (I, 16). \i'iT!Jen t he pa-
t ient's serum is allowed to stand overnight at 
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4oC, a heavy "cream" layer of chylomicrons is 
observed on the surface with turbid pre-[3 
lipoprotein-containing serum below (Table 
III). Low activity of lipoprotein lipase activity 
accounts for the chylomicronemia. Eruptive 
xanthomas and abdominal complaints are seen 
as iu other lipemic syndromes. 
Underlying or secondary diseases can cause 
hyperlipoproteinemia, xanthomas and symp-
toms t hat mimic t he primary familial syn-
dromes. For this reason, appropriate laboratory 
studies must be clone in all patients with hy-
pcrlipoproteinemia to determine t he presence 
of such diseases as diabetes, nephrosis, llypo-
t byroidism, etc. (Table II). 
Obstructive liver disease causes an elevation 
in [3-lipoproteins. However, it has been shown 
t hat this {3-lipoprotein is different from those 
found in either normal individuals or t hose 
with Type II hyperlipoproteinemia (19). Im-
munologic techniques demonstrate that the 
apoprotein of the [3-lipoprotein in obstructive 
liver eli ease is different and that this distinc-
t ive apoprotein permits t he lipoprotein t o 
carry unusually large quant ities of free choles-
terol. It is for this reason that such patients 
TABLE IV 
FORM S OF XANTHOMA FOUND IN 
!-IYPERLIPOPROTEINEMIC DISTURBANCES* 
Frequency of various 
forms of JI.Onthomos 
in primary and 
seconda ry diseases 
Primary 
disturbances Type U 
Secondary lipoprotein Obstrucllve 
disturbances liver disease 
Usual lipid and 
lipop rote in 
ollerotioos (3 o' Sf 0 -20 
T endinous and planar xrmthomas are most 
comm only foLmd with t3-lipoprotcin :.tl te rawons, 
whil e e r11pti ve xanthom as occur in Lhc p resence 
of chy lomicrons and prc-[3 li poprotein disLnrb-
ances . Tuberous xan Lhomus co rrelate most; closely 
w ith increases in prc-[3 lipoprot.e ins. 
"' P [L\.Lc rned ahcr Scoggin. an u Tlarbn (40). 
have greater t han normal V[dues of plasma 
free cholesterol and reduced cholesterol ester 
(21). 
A number o£ secondary diseases may present 
lipoprotein alterations similar to t hose seen in 
t he various familial hyperlipemic syndromes 
(Table II) (22-39). Thus, diabetes mellitus 
may present wit h a chylomicronemia and low 
levels of lipoprotein lipase very much like 
Type I syndrome except that with insulin 
therapy the normal activity of t his clearing 
enzyme is achieved (7, 22, 23). Occasionally, 
high levels of pre-[3 lipoproteins are seen in 
diabetics mimicking T ype IV or V syndromes. 
Chronic pancreatitis (24, 25), chronic non-
nephrotic uremia (26), lipemia secondary to 
alcohol ingestion (27-30) and lipoatrophic 
diabetes (31) have been reported to cause 
xanthomatosis associated with variable in-
creases in chylomicrons and pre-/3 lipoproteins . 
Recently t he occurrence of chylomicronemia 
has been reported in two patients with lupus 
erythematosus and one patient wi th lymphoma 
(32). 
Last, ~1 s shown ill Table II, myxedema , 
nephrot ic syndrome, estrogenic-gestational hor-
mones and pregnancy may result in {3, pre-/3 
and chylomicron elevations associated with 
xanthomatosis (34, 37-39). Of particular in-
terest are the few reported cases of multiple 
myeloma and leukemia associated with or with-
out lipemia and widespread planar xanthoma 
(35, 36) . 
R elationship of Primary and Secondary 
l-IyperlipoJn·oteinemias to Specific 
Forms of Xanthomas 
The clinical forms of xanthomas are corre-
lated with the five primary hyperlipoproteine-
mic syndromes as well as t he secondary diseases 
with associated hyperlipoproteinemia in T able 
IV (40). 
As can be seen, t he clinical form of xantho-
mas found in each patient cannot be used to 
diagnose specifi c disease entit ies, but careful 
notation of t he skin lesions can lead to rea-
sonable generalizations. The finding of tendi-
nous xanthomas, particularly in association 
with planar xanthomas or xanthelasmas, sug-
gests an underlying [3-lipoprotein disturbance, 
while eruptive xanthomas allow t he physician 
to ant icipate lipemic serum associated with in-
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creases in chylomicrons or pre-(3 lipoproteins. 
Tuberous xanthoma most closely correlates 
with in creases in pre-/3 lipoproteins. 
Th era py of I-i yped ipo proteinemic Condi tions 
Associated with Xanthomatosis 
Lowering plasma lipoproteins wi th diet 
and/ or drugs re uhs in the complete resolu tion 
of cert::tin xanthomas, particularly eruptive and 
tuberous lesions. Whether dietary or drug ther-
apy is equally effective in resolving atheroma-
tous plaques is an unanswered question . 
N everthele s, in patients wi th hyperlipopro-
teill emia, such therapy would seem justified not 
only in t he hope of reducing the great hazard 
of accelerated atheromatosis, but in t he pre-
vention of pancreatit is and disabling abdomi-
n al pain occasionally encountered m hyper-
lipemic conditions. 
Figure 2 illustrates the action of certain 
drugs and specific diets on lipoprotein metabo-
lism. Clofibrate, nicotinic acid , d-thyroxine and 
cholestyramine have sp ecific effects on f3 and 
pre-(3 Lipop roteins. Clofibrate is particularly ef-
fective in decreasing plasma pre-(3 lipoproteins 
by virtue of its interference with cholesterol 
synthesis in the liver and perhaps its preven-
tion of t he release of t hese lipoproteins into the 
circulation ( 41, 42) . N.icotinic acid lowers both 
(3 and pre-(3 lipoproteins by preventing their 
release from the liver as well as blocking free 
fatty acid (FFA, Fig. 2) mobilization from 
adipose t issue. The increase in catabolism of 
cholesterol to bile acids, with subsequent exces-
sive loss of bile acids t hrough the gastro intes-
t inal t ract, is apparently the mechanism by 
which d-tbyroxine lowers plasma (3-lipopro-
teins and consequent ly plasma cholesterol (41). 
Cholestyramine, an anion exchrmge resin, 
lowers (3-lipoproteins by binding bile acids in 
t he gastrointestinal tract , and thus prevents 
t heir reabsorption via t he enterohepatic path-
way. By accelerat ing the loss of the b il e ncicls 
t hrough intestinal loss, t he liver cholesterol 
pool is diminished and therefore less sterol is 
available for synthesis of (3-lipoproteins ( 43-
45) . 
Dietary manipulations can affect the metabo-
lism of f3 and pre-/3 lipoproteins and cbylomi-
crons. Polyunsaturated fats in the di et may de-
crease cholesterol ab orption which in turn 
lowers (3-lipoproteins. Low carbohyd rate di ets 
Ll 
SITES WHERE THERAPY IMPROVES 
HYPERLIPOPROTEI N ABNORMALITIES 
li'ra. 2. The points (numbered 1-7) nt \\·hich 
vnrious drugs :mel dietary manipulations inlerfere 
with cholcsLerol ( cbolest.) and Lriglyceride (TG ), 
as well as lipoprotein metabolism, are shown. 
Poin t 1. Interference wi th the relea e of lipopro-
Leins from the liver : Speculative fo r clofibrate 
(A tromid-S®) and nicotinic acid (NicaJex®). 
Point B. Interference with the synthesis of cho-
lesterol in Lh e li ver and possibly other tissues: 
Clofibrate is 1 articul arly useful in lo\\'ering pre-,B 
lipoproteins. presumably via this mechani m. 
Point 3. Increased cataboli m of cho lesterol to 
bil e ·ails and subsequent loss in t he stool: D-
thyroxine (Choloxin®). 
Poinl 4. InLerference with the reabsorption of 
hile salts : Cholesty ramine ( Cu emid®, Questr:m®). 
Partirulnrly usefu l jn lowering ,8-l.ipoproteins. 
Point. 5. Dietary effects : Low cholesterol intake 
ma:-· decrease the plasma. cholesterol b:v ~mall 
nmounls. Polyunsaturated fals n.lso decren e plasma 
chole terol (,B-lipoproteins). bu t the mechanism is 
Jlo t cl early understood. Some investigators hypoth-
size it is due to prevention of dietnry cholesterol 
abso rption , while others claim it is th e result of a 
rrdistribuLion of circulnting cholesterol into the 
tissues. Low carbohydra te diets decre::1se the s,·n-
thesis of gl~r ce ro l iti the liver and t hereby lo;ver 
pre-,B lipop roLeins. Low-fat diets prC\·ent the for-
mation or chvlomicrons. 
Po·inl. 6. Ci ar:lll ce of chylomicrons from the ir-
cul nt..ion: Removal of tbese lipopro Leins depends 
on li popmtein lipase enzy me activitv which in 
lurn requires adequate levels of insuiin, th\roid. 
and endogenous heparin. Thus diabet·es mell iLus, 
myx dema patients nod some indivi luals with SYS-
temic lupus eryLhemaLosus may develop cll):lo-
mieroncmia. 
Point. 7. In terference wi th Lhe rei use of free 
fatly acids from stored uclipo e cell t riglycerides : 
Without adequate d livery of f ree fa tty acids to 
the liver. triglyc ·ride syn thesis is impa ired. One or 
l.hC' effec ts of nicotinic acid (Nicalc:-:®) . 
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decrease the fo rmation of pre-f3 lipoproteins, 
presumably by decreasing the amount of 
hepatic glycerol available for endogenous tri-
glyceride synthesis (5, 6) . Restriction of fats or 
triglycerides in the diet prevents the formation 
of cbylomicrons in the intestinal wall and 
t herefore is useful in lowering blood levels of 
these lipoproteins. 
The activity of lipoprotein lipase (LPL), 
the important enzyme t hat clears cbylomicrons 
from the circulation, fluctuates with the avail-
ability of insulin. Some patients with diabetes 
mellitus may develop severe chylomicronemia 
due to insulin insufficiency and when exoge-
nous insulin is given, normal LPL activity is 
restored and chylomicrons are cleared from the 
circulation (7). LPL activity also apparently 
depends on its release :mel activation by en-
dogenous heparin. Glueck et al. (32) have 
recently reported on several patients with 
high circulating levels of immunoglobulins 
(SLE and lymphoma) and chylomicronemia . 
Evidence was presented by these authors to 
show that the immunoglobulins bound endoge-
nous heparin and thus prevented LPL activa-
t ion. LPL activity also seems to be affected by 
uremia, thyroid hormones and estroge11ic drugs 
T ABLE V 
DIETARY AND DRUG THERAPY 
IN PRIMARY HYPERLIPOPROTEINEMIA 
Lipoprotein 
Type E levation Dietary Therapy Drug Therapy 
I Low fat 
Chylos 
Low co loriei low Cholesty romin e, 
II f) cha lest.; high D· Thyroxine or polyunsaturated Nicotinic acid f3 fat 
d) Low ca lorie , Clof ibrat e or m low cho lest.; Nicotinic ac id 
f3 pre-{3 low carbo. 
iP Low co lorie ~ Clofibrate or Ill low carbo. Nicotinic acid 
pre· f3 
• 
Low calorie; Clofibrate or 
-:sl low carbo; Norethindrone 
low fat acetate 
pre·f3 Chylos 
The approp riate dietary and drug 1,herapy for 
each of t he five prima ry hypel'lipoprote inemic 
condi tions arc listed. 
since cerlain patients with chronic renal fail-
ure, myxedema and t hose on c011traceptive 
medications may have low levels of this clear-
ing enzyme and chylomicroncmia (Table II). 
Since the various drugs and dietary altera-
tions depicted in Figure 2 are relatively spe-
cific in their action on the fo rmation and/ or 
degradation of each lipoprotein, it becomes im-
portant for the clinician to identify the lipo-
protein aberration in each patient before de-
ciding on the therapeutic approach. The ap-
propriate dietary and drug therapy recom-
mended fo r the primary hyperlipoproteinemic 
conditions is presented in Table V. Excellent 
reviews covering t his topic can be found by 
Harlan (46) and Fredrickson (·17). 
Dietary therapy will partially lower pl::tsma 
lipids in most patients with one. of t he primary 
hyperlipoproteinernic syndromes. For this rea-
son, patients with these condit ions should be 
placed on an appropriate diet before utilizing 
drugs. Since the genetic deficiency of LPL 
responsible for Type I hyperlipoproteinemia 
cannot be treated wit h drugs, a diet of less t han 
35 gm/day of fat is effective in preventing the 
formation of chylomicrons (Table V). Patients 
with Type II lipoproteinemia require co loric 
ad justments to maintain ideal body weight, in 
conjunction with rest riction of dietary choles-
terol. The addi t ional use of polytmsaturated 
fats will also aid in decreasing {3-lipoproteins, 
the sum total of t hese manipulations some-
t imes lead to 15-20o/o reductions in {3-lipopro-
teins in t he circulation. When pre-{3 lipopro-
teins are elevated, as in Type III-V syndromes, 
low caloric diets ,vjtb restri ction of carboh y-
drate are most crit ical. Restriction of dietary 
chole. terol is also usually recommended in 
Type III syndrome. In patients with Type V 
hyperlipoproteinemia, both fat (triglyceride) 
and carbohydrate induced lipoproteins are 
elevated and moderate restrict ion of both kinds 
of foods are required to reduce these li popro-
teins. 
Although many drugs have been suggested 
for lowering lipoproteins, five that have seemed 
most beneficial are listed in Table V. Choles-
tyramine, when given in divided doses total-
ling 16-32 gm/ day, J1as resul ted i11 greater 
reductions of f3-lipoproteins than diet alone 
achieves in patients with Type II syndrome. 
Clofibrate is the drug of choice for reducing 
pre-f3 lipoproteins fouml elevated in Types 
:XANTHOMA'l'OSIS 79 
III-V, if diet alone is not totally effective. D-
thyroxine and nicotinic acid have also been 
adYOC~I ted for lo\\"eri ng (J n nd pre-(J lipopro-
teins, but the side effects of these two drugs are 
often so bothersome that their usefulness is 
limited. Recently Glueck et al. ( 48) have re-
ported on tile effectiveness of a progestn,tional 
drug, norethindrone acetate, in reversing the 
lipoprotein alterations in Type V hyperlipopro-
tc inemia. 
Recent Lipid Bioch mical a11d Ultrasiructuml 
St1tdies on Xanthomas 
tucl ies by Montgomery and 0 terberg ( 49) 
and Lever and co-workers (50) first related 
high plasma lipids to xanthoma formation. 
A11rens and Kunkel (21) subsequently demon-
strated thn,t the level of total serum lipids was 
critical in predicting when these skin lesions 
would appear or disappear. Such studies sug-
gest pl::tsma lipids significantly contribute to the 
lipids accumulating in xanthomas and thus may 
be important in the f~rmation of these lesions. 
Two recent studies are in accord with this sup-
position. Scott :mel Winterbourn (51) clemon-
trated that radioactively labeled lipoproteins 
accumulate in human xanthomas. Wilson (52) 
postulated that xanthoma lipids originate from 
the plasmn, when he provided evidence that 
cholesteTol, one of the major lipids found in 
x:~nth omnta, is not s~ ·ntb es i zed i11 sit1t . 
Perhaps the best evidence for the plasma 
ori.,.in of xanthoma lipids comes from experi-
mental animal studies utiLizing correlative 
Lipid analytical, histochemical and ultrastruc-
tura l techniques. Experimental xanthomas with 
hi. to logic and biochemica I ch:uacteristic re-
sembling human xanthomn, can be J roduced in 
monkeys (53, 5-!) and rabbits (55-58) fed 
high cholesterol di ets. As is the case in many 
forms of human xanthomas, cholesterol, par-
ticularly in the esterified form, is the major 
lipid accumuhtino· in both the plasma and 
xanthomata. By using t he fatty acid patterns 
of cbolesterol esters as a marker, it ha s been 
possible to infer the origin of xanthoma cho-
lesterol ester. in rabb its. After four II'Ceks o[ a 
hig:h cbole. tcrol di et, and coucomitan t with the 
appea rance of the first x::ml.hom.1 s, pbsma and 
xanthoma fatty acid patterns are identical 
(59). This similarity in plasma and xanthoma 
cholesterol esters suggests t hat in the rabbit n, 
major portion of these lipids found in xan-
1 ~ • d f . I thoma m-e denve rom the plasma. Sunu tane-
ous electron microscopic studies on the devel-
oping xanthomas in rabbits provide additional 
evidence for the plasma origin of xanthoma 
lipids since lipoprotein droplets are detected in 
the dermal capillary walls, perivascular spaces 
~wei 11·i1 hin caJ ill ary perithelial cell s (Fig. 3). 
These droplets are in comparable positions in 
the capillary wall to the droplets observed in 
frozen sections stained with oil red 0. Also, the 
droplets appear at the tin1e when plasma and 
xanthoma cholesterol esters come to resemble 
one another nnd when the dermal cholesterol 
ester concentration fir~t increa es (60). 
In man the similarit ies between blood and 
xanthorna. lipid [lrc no t so p recise. Recent 
analytical studies by a number of investigators 
( 18, 61-64), correlating the amotmts and types 
of lip ids accumulating in various forms of 
xanthomas with the lipids found in the circu-
lating li poproteins, report cholesterol (particu-
larly cholesterol esters) to be the predominant 
li pid in t he skin lesions regardless of whether 
hypercholesterolemia or hypertriglyceridemia is 
present. These investigations dealt with tendi-
nous, planar, tuberous and even eruptive xan-
thomas as ·ociated with some of the primary 
famili al syndromes. Baes ::mel co-workers (18) 
stucliecl patients with Type IV syndrome with 
eruptive xanthomas and high plasma triglyc-
ericles and they found that cholesterol was the 
predominan t lipid in the xanthomas. 
When the fatty acid patterns of cholesterol 
esters are compared in xanthomas and plasma 
lipoproteins, even greater dis imilari tie- arc ob-
served (l , 61-64). Xanthomas contain grently 
increased amounts of cholesterol oleate and de-
creased chole ierol linoleic acid in re pect to 
the plasma (61, 62). Thus xanthoma choles-
terol esters do not precisely reflect those found 
in the plasma, and if these lipids do primarily 
come from the plasma, they must undergo con-
sidern ble metabolic alteration once they are de-
posited in t he lesions (61, 62, 64) . 
To emphasize t he complexity of the patho-
logic events occurring within human xantho-
mata and in nn attempt to resolve some of the 
conflicting in[ormation on xanthoma lipids, the 
re ·ults of three recent investigations by the 
authors will be briefly reviewed. 
Studies of Diabetic Eru1Jtive Xanthomas. 
Patients with diabetes mellitus may occn,sion-
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Fw. 3. Rabbit xanLhoma after 10 weeJ,s of cholesterol feed ing. The profile of a derm al 
capillary with a patent lumen is shown in cross section. T he endothelial c .\ls (E) main-
tain their close connections with one another. Lipid clropleLs (D) arc seen in Lerposecl bei\\'CCD 
the endothelial cells and the capill ary peri thelial cell s (P) as well as wi t.hin lhe cap ill ary 
basal lamina (B). Al though not shown in thi. micrograph , similar clrOlJicls nre ::tl so found in 
Lhe peri vascular extraceUular space and in close proximity lo foam cell s (F) found n ar t he 
dermnl capill aries. These cells contain numerous vacuoles which apparenW:v co nt.ainccl li pid 
material whi ch has been extracted b:v the fi xation procedu re. The peri thelial cell s also nc-
cumula le lipid containing vacuoles in their c~> lop l asm. X 4,500 
n ll~· dc,·c'op n sev 'rc chy lomicronemi::1 r csem-
IJiing Typ I fam ilia l hyped ipoprotein emia 
wit h high levels of plasma t riglycerid es due to 
decreased lipoprotein upase activity (Table II) 
(22, 23). When t he erupt ive xanthomas first 
appear, t hey con tain 45% t riglyceride and 25% 
cholesterol. The chylomicron t riglycerides have 
a fatty acid pattern identical to t he xanthoma 
t riglycerid e fatty acids suggesting t hat the 
former . ignificantly cont ribute to t he t riglyc-
eridcs accumulat ing in t he skin. Oil red 0 
stainin()' of erupting lesions displays fat drop-
let. in t he dermal ca.pillary walls, and electron 
microscopy of tbe same vessels r eveal droplets 
in ident ical posit ions in the vascula.r basement 
membrane and out in the extracellular space 
(Fig. 4) . Th ese droplets have the same range 
of sizes (2000 ± 1000 A) and ult rastructural 
configuration as chylomicrons in the circulation 
(2-4) . Foam cells in these xanthomas can b e 
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F IG. 4. Human diabetic eru pLi1·e xanth oma.. A por tion of :1. dermal capill nr.'· is shown 
runuing along Lhe lower one-half o f the microgra ph and extending u p the left side of the 
picture. The lumen ( L ) can be identified, outlined by several endolhcli nl cell s (E). A 
1 eritheliul cell (P) wi th severn! lipid con lnining vacuolt'S is een us pa rl of Lh e c:1pil br.1· " ·all , 
whi le n. ~ rn all portion of n, mncr011hag foam r.ell (]VI) is observed in Lhe UJ per righ t, co m er . 
Between the cnd oLhc.Lial nnd pcri LheliJJ.l ce ll s, wi thin Lhe basal lamina. (B) of t he vessel wnll , 
numerous li pid cl ropleLs (D) arc present. Similar droplets are seen beyond lhe basnllamina 
cl ose to th e mncrophngc. These droplets, li ke t hose in experimental rabbi L xanlhomns, arc 
believed lo rep resent e h~· l o mic ron s in t ransit. .from Lhe circul at.ion Lhrough llw rlermal copil -
lnr~r wall. It is then post ula ted t.ha t the c li pid particles arc seq uester d b~· pcri thcli :1 l cells 
and Lissue macrophuges whi ch C\·oh ·e in to foa m cell s . Iucleu · (N ). X 5,649 
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iden t ifi ed as originating from Li.:suc tm cro-
p h:q:?; es n.nd peri t hel ial cell (Figs. 4, 5) . The e ul-
t r a.-tru ctura l studies t::t ken in conjunction wi th 
t he his tochemical and analytical studies sugges t 
t ha t circula t ing t ri rrl~·ce rid e-ri ch chy lom ic rons 
p ermeate Lhe derma l c:Jpillary walls and a re 
t hen sequ estered b y tissue macrophage and 
]!erilhelial cell. whi ch evolve into foa m cells . 
Indeed , t he resul t s of t hese studi es on di abetic 
erupt ive x:Jn t hom as arc very simila r to t hose 
ou tlined preYiously in rcg:J rd to rxprr imrntal 
xant homas in choles terol-fed r abbits. H owever , 
t be correlation of p lasm a. and x:1nt hom a lip ids 
in m~m and rabbits is different. In diabetics, 
t r iglycer id e-rich xanthomas chemically rciiect 
th e lwpcr t riglyrerid r min, wh il e in r .1 hbi is i1·, is 
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Fm. 5. Human diabetic eruptive xanthoma. A po rtion of a macrophage foam cell is shown . 
N umerous li pid coDtaining vacuoles (F) arc interspersed between prominent lysoso me or-~n n ell rs (LY) . Such cell s make up the majority of Lhe foam c lis in xanthomas. N ucl eus (N) . X 6,756 
cholesterol which is the major lipid found in 
the l ions as well as the various lipoproteins 
including chylomicrons (65). The ult rastruc-
tur:ll findings in xanthomas of the two species 
is nlmost identical and arc t hought to be t be 
first morphologic evidence suppor ting the 
bypothe. is t hat plasma lipoproteins contribute 
to the formation of xanthomatous lesions (65). 
Ini tiation of insulin therapy to diabetics with 
chylomicronemia results in the clearance of 
chylomicrons from the circulation and a con-
comi tant resolution of the xanthomas. When 
xanthomas are sequentially studied during their 
disappea rnnce, triglyceride in the lesions is 
mobili zed more rapidly t han cholesterol, result-
ing in a redistribu tion of the xanthoma lipids 
so t hat the initial t riglyceride-rich lesions are 
conver ted to resolving xanthomas which con-
tain mainly cholesterol. Correlative electron 
microscopy reveals loss of lipid material from 
t he foam cell vacuol s and a foldin g of the 
limit ing vacuolar membranes. These findings 
demonst rate that lipids can be moved out of t he 
xanthoma foam cells but apparently the rate of 
removal varies for each lipid. Obviously, the 
rates of removal and deposition of various 
lipids or lipoproteins will a.Jiect the lipid com-
position of xanthom.'ls. T!Jis may help to ex-
plain some of the differences in lipid content 
observed between xanthomas and plasma lipo-
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protein t hat hnxe been reported in severa I 
studies ( 1 , 61-64). 
Studies of Eruptive Xanthomas in Type V 
Famil·ial HyJJ erlipOJJroteinemia. The results of 
a tucly on a 25-yenr-olcl fema le with eruptive 
xanthom:ls and marked lipemia are summarized 
in Figure 6. On month after t he onset of t he 
xanthomas, t he lipid content of t he lesions was 
found to be 51 o cholesterol and 17% t riglyc-
eride. At t his t ime t he pre-(3 lipoproteins were 
the principn l plnsma lipoproteins, although 
30% of the plasma cholesterol and triglyceride 
was ca rri ed as chylomicrons. When t be patient 
wa placed on a 40% high fat diet for 10 days, 
t r irrlyceride-rich chylomicrons became the pre-
dominant plasma lipoprotein and the lipid 
composition of the eru p tive xanlhom:1s ch:1nged 
so t hat t riglycerides became t he mnjor lipid 
( 41%) with cholesterol cont ribu t ing only 24% 
to t he total li pid content (Fig. 6). The rise in 
chylomicrons in t he circulation is explained by 
t heir increased formation in the intestinal 
wall in response to the administered high fat 
diet. It is of interest that the eruptive xantho-
mas associated with T ype V hyperlipoprotein-
emia, when sampled init ially, have a different 
]jpicl campo. it ion than those of diabetic pa-
t ients in that Type V lesions are cholesterol-
ri ch, presumably refl ecting the contribution the 
plasma pre-/3 lipoproteins make to t hese le-
sions. It is possible, however, to alter t he lipid 
composition of the eruptive xnnthomas by 
dietary manipulation. The predominnnce of 
chylomicrons in the circulation i11duced by 
high-fat di et apparently increases the deposi-
tion of these t riglyceride-rich particle in the 
xanthomas causing a significant increase in the 
triglyceride content of these lesions. 
Studies on Ihmwn X anthelasmas. Esterified 
cholesterol is the mnjor lipid found in xanthe-
lasmas, representing 55-80% of t he total lipid 
nccumubting in tbesr lesions. Free chole terol 
cont ribu tes 5-15% of the lipid. In nine patients 
studied with Type II /3-lipoproteinemia, the 
fatty acid patterns of the cholesterol esters 
found in xan thelasmas significant ly differed 
from t,he fatty acids found in the /3-lipoprotein 
cholesterol esters. The xanthoma show more 
cholesterol oleate (18 : 1) and less linoleate 
(18:2) t han the plasma lipoproteins. A similar 
finding has been reported in tendinous and 
tuberous xanthomns (61-64) . 
STUDIES ON ERUPTI VE XANTHOMA AND LIPOPROTEINS IN 
A PATIENT WITH TYPE 11: SYNDROME 
XANTHO MA LIP I OS 
(% of tota l lipid 1n ~~:on thomo) 
CI RCULATING LIPOPROTEIN LIPIDS 
(% plasma lipid carr ied in each LP) 
i Chylo pre-/3 ~ 
' p 
Tc· TG' 
32% 37% 
42% 64% 
27 % 5% 
AFTER 10 OAYS ON 40% HIGH FAT 0 1 ET 
•rc•totol cholutercl 
t TG• tri;lycedde 
TC TG 
24% 41% RChylo 
~~•·P 
TC TG 
60% 87% 
30% 12% 
10% 1% 
Fra. 6. D:1Ln summarizing Lata! cholcsle rol (TC) 
a_ud t riglyceri de (TG) dist rib u tion in hu man crup-
t:.-c xanth~mns and plnsmrc .l ipoproteinE in :1 pn-
llcnt W! th T.\'1 C V S_\'Uci rome, bcio re and nfle r in-
gesting a high-fat di L. 
Recent ultrastructural tudies baYe ut ilized a 
new method of fL'Xation which retains free 
cholesterol t hat is normally extracted by the 
usual methods of fixation (66) . Chnracteristic 
chole terol con.fio·u rations or "spi cul e~·, are ob-
se r"ed in such xn nthomns when fi:xed in a cligi-
tonin-a.ldehycle solutio11. These free cholesterol 
configurations are seen within both the perithe-
lial cells of capiJJaries and in macrophage foam 
cells (Figs. 7, 8). 
These correlative ultrastructural and lipid 
analytical studies on xanthelasma sugge-t that 
cholesterol in the circulation crosses the capil-
lary cnc!othelium and i ~ then sequestered bv 
foam cells. However, t he differences in chole; -
tcrol ester fatty acids fo und in xanthelasmns 
and t he circulation suggest that there is not a 
direct deposition of plasma cholesterol e-ters in 
xanthomas. Instead, there may be modi fication 
of the accumulating cholesterol by selective up-
take of certa in e ters, hydrolysis and rcc~teri fl­
cation of other cholesterol esters I j the foam 
cells in the xan thomata, or esterification of free 
cholesterol equestered from t he c irc ui ~Hion by 
foam cells. 
The R elationship B ctwePn Xa nthomas 
and Atheromas 
How precisely the structural and lipid bio-
chemicn l eYents occurrin o- in xanthomas reflect 
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Fw. 7. Human xanthelasma associated with T ype II primary hyperli poproLeincmia. A 
digi tonin-con taining aldehyde solution was utilized for fixing this specimen in order to 
reLain free cho.l esterol within the tissue (66). Characteristic cholesterol "spicules" (CS) 
which appear as tightly packed concentric lamellae are observed within dermal capillary 
endoLh elial cells (E) as well as in portions of vacuoles found in an adjacent perithelial cell 
(P) . Lum en of the dermal capillary (L) . X 8,959 
simult aneous :mel analogous a lterations in large 
vessels is no t entirely known. However, there 
nrc enough similarities between the two types 
of lesions i"o suggest that xa nthomas may be a 
usefnl model system from which relevant de-
ductions can be made regarding the pathogene-
sis of atherosclerosis. 
The ma.jor lipid found in vascnlar plaques is 
elwlesterol, particularly esterified cholesterol 
which appea rs to be primarily deri ved from 
circu][]Liilg lipoproteins (67-73). Wi th t he ex-
ception of diabetic eruptive x:mthomas, cho-
lesterol c·~Ler is ::dso tbe main li pid found in ex-
perimental and Y::mous human xant.honias 
studied to da te (57-64) . Biochemical and ul-
t rastructural evidence summarized iu t his re-
view would also suggest t hat the major source 
of xnnthoma li pids, even in triglyceride-rich 
din betic eru ptive lesions, is a!. o from circulat -
ing li poproteins (51). 
The acc umulation of foam cells in t he intima 
of Iaro-e vessels seems to be analogous to the 
congregation of lipid bdcn cells around derm:l l 
capillnrics in xant homas. Presumably cells of 
bot h t issues sequester plasma lipoproteins once 
they have permeated the endothelium ::mel 
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l''w . . Human x:tu Lhclnsma a.socia lr d " ·i Lh T~· JX' II primnr~· lly pcrli po proiP in Pmia . Dig i-
lonin-:clcle hn le fi xat ion to re lain free <' ho les le ro l. A po rlion o r a m::tc•ro phap;e foa m eell is 
shown wi Ll. . a p:trL o f il s nucl us (N) pi ctured on t lw ld l.. Se,·rral vneuoles a re SPen wiLhin 
I he cy lopl a ·m a nd Lwo o f Lhesc con ta in C'ho lrslc ro l "spi cul e:;" (CS ) . T llf'sp a rc seen lo h 
I ightly packed co necn Lric lamell ae. X 18.809 
these cells evolve in to foam cells. In the case of 
large muscular and ela stic ar teries, t be im-
bibed lipopro teins a. re apparently impeded by 
Lhe internal ela t ic lamina and elicit t he move-
men t of . mooth mu cle cells of t he media into 
t he intima (74, 75) . These relocated mooth 
muscle cells, cal led myo-in timal cells, accumu-
late lipid and cont ribute to the foam cell popu-
lati on of t he p laque alono- with tissue macro-
phages (73, 74) . In a somewhat similar fash-
ion, lipop roteins appear to be retarded by t he 
dermal cap illary ba sement membrane, and t he 
peri tbeli al cells of t he capillary wall display 
lipid inclusions and ul trastructural altern tions 
comparable to t he myo-intimal cells (60, 65). 
This suggests, fi rst, i.h:1t peri cytes might be 
analog:ous to smooi h nw:·(' ]c celb of b rgc blood 
ves el. and, second , t hat bo th cell t ypes react 
to hyp erlipop roteinemia by sequestering lipids 
in t he same manner . T i sue macropbages pln.y 
a more predominan t role in xnn thoma foam 
cell formation t han in atheromas, probably be-
cause grea ter numbers of these cells are found 
in dermnl connective t issue t han in the vessel 
II' all. 
Add itional p:u a Lle1.· can b cited re.,.ard inn· 
atheromas :-tnd xan1 hom:1s. Bolh les i on~ ha.v~ 
been shown to be a cti v e]~· m iaboli zing t issue 
cnpable of effect ino· :-t ltern. t ion in t he deposited 
plasm:1. lip ids and even yn thesizing certa in 
lipid._ in sittt . For example, comparison of lipid 
composition of xantlw ma :-t nd atherosclerotic 
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lesions shows a sLriking resemblance between 
the fatty acid composition of cholesterol ester 
fract ions of the xanthomata and the fatty 
streaks of human and experimental animal 
aortas (59, 76, 77) . These cholesterol ester 
fatty acid patterns in both kinds of lesions 
contain greatly increased amounts of oleic acid 
at the expense of linoleic acid when compared 
to the cholesterol esters in the circulation . 
Thus, t here would seem to be highly selective 
processes in operation leading to the accumula-
tion of particular kinds of cholesterol esters in 
xanthomas and atheromas, and it seems that 
t hese processes are analogous in the skin and 
vessel wall. Stil l :mother metabolic simil arity 
has been observed to exist between xanthomas 
and atheromas in that phospholipids and free 
fatty ac ids found in these lesions are appar-
ently primarily derived from synthesis in situ 
(52, 78-81). 
The studies summarized in this review dem-
onstrate that the lipids found in xanthomas, 
which play a vital role in the formation of 
these lesions, do not simply result from the 
passive deposition of blood-borne lipoproteins. 
The kinds and amounts of lipid found in xan-
t homas (as well as atheromas) are t he result of 
a complex series of metabolic reactions which 
may involve hydrolysis and t ransesterification 
of deposited lipoprotein lipids, locn,l synthesis 
of certain lipids and the mobilization of various 
lipids back into the bloodstream. Little is 
known about the relative importance of these 
reactions and more investigative effort is needed 
to clarify the various metabolic alterations. 
Further studies along these lines would seem to 
be worthwhile in view of the possible in ights 
this may provide toward understanding the 
atherosclerotic process. 
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